Telomerase Reverse Transcriptase-mutated Follicular Variant Papillary Thyroid Cancer With Tibial Metastasis

端粒酶逆转录酶突变滤泡变异型乳头状甲状腺癌伴胫骨转移

阅读:2

Abstract

Follicular variant of papillary thyroid carcinoma (FV-PTC) generally has a favorable prognosis but can behave aggressively, notably in the presence of TERT promoter mutations. We present a case of a 58-year-old woman with a remote history of thyroid cancer treated by total thyroidectomy without radioactive iodine, who presented with acute right leg pain. Imaging revealed a destructive lesion in the right proximal tibia with biopsy-proven metastatic FV-PTC. Her thyroglobulin was >500 ng/mL (> 500 µg/L) (reference range: < 35.00 ng/mL; < 35.00 µg/L) and was above the assay detection despite dilutional efforts. She had undergone surgical resection of the metastatic lesion with a pathology consistent with FV-PTC. Molecular testing identified TERT promoter mutation c.124C > T. She had received radioactive iodine treatment, and subsequent posttreatment whole-body iodine scan revealed iodine-avid lesions in the right tibia and posterior second rib. Appendicular skeletal metastasis of papillary thyroid carcinoma is not well established in large cohort studies but in single institution studies reporting incidences of approximately 1% of thyroid carcinomas. This case highlights the potential of late-onset and aggressive metastatic spread of TERT promoter mutation FV-PTC and the necessity of dynamic risk assessment to ensure early identification of recurrence to guide treatment decisions.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。